Stockscreener 앱 받기
2.11
2.76%
-0.06
시간 외 거래:
2.14
0.03
+1.42%
전일 마감가:
$2.17
열려 있는:
$2.13
하루 거래량:
183.07K
Relative Volume:
0.44
시가총액:
$199.51M
수익:
$72.76M
순이익/손실:
$35.34M
주가수익비율:
5.7135
EPS:
0.3693
순현금흐름:
$-62.91M
1주 성능:
-4.52%
1개월 성능:
+17.88%
6개월 성능:
+58.65%
1년 성능:
+33.54%
1일 변동 폭
$2.09
$2.145
1주일 범위
$2.09
$2.35
52주 변동 폭
$1.13
$2.38
Compugen Ltd Stock (CGEN) Company Profile
Compare CGEN vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CGEN
Compugen Ltd
|
2.11 | 205.18M | 72.76M | 35.34M | -62.91M | 0.3693 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-07 | 개시 | H.C. Wainwright | Buy |
| 2025-01-13 | 개시 | Oppenheimer | Outperform |
| 2022-08-05 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-05-26 | 재개 | JMP Securities | Mkt Outperform |
| 2020-05-13 | 개시 | Stifel | Buy |
| 2020-05-07 | 개시 | SVB Leerink | Outperform |
| 2020-04-22 | 개시 | ROTH Capital | Buy |
| 2020-03-24 | 개시 | SunTrust | Buy |
| 2020-01-16 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-03-29 | 개시 | Oppenheimer | Outperform |
| 2016-02-01 | 재개 | Oppenheimer | Outperform |
| 2015-10-15 | 개시 | FBR Capital | Outperform |
| 2015-04-23 | 재개 | Jefferies | Buy |
| 2015-04-21 | 개시 | Oppenheimer | Outperform |
| 2014-02-07 | 개시 | MLV & Co | Buy |
| 2009-12-28 | 재확인 | Cantor Fitzgerald | Buy |
| 2009-07-29 | 개시 | Cantor Fitzgerald | Buy |
모두보기
Compugen Ltd 주식(CGEN)의 최신 뉴스
Retail Trends: Will Compugen Ltd outperform the market in YEARWeekly Gains Summary & Real-Time Volume Surge Alerts - baoquankhu1.vn
Compugen Ltd. (NASDAQ:CGEN) Q4 2025 earnings call transcript - MSN
Compugen shares jump nearly 5% after strong Q4 earnings beat - MSN
Compugen (CGEN) director discloses initial share and option holdings - Stock Titan
[Form 3] COMPUGEN LTD Initial Statement of Beneficial Ownership - Stock Titan
Compugen (CGEN) director Eran Perry details shares, RSUs and options - Stock Titan
Compugen (CGEN) CMO Michelle Mahler details option and RSU holdings - Stock Titan
Compugen (CGEN) director Mathias Hukkelhoven details initial equity holdings - Stock Titan
Compugen (CGEN) director Holcomb reports shares, options and RSUs - Stock Titan
Halevy Gilead discloses initial Compugen (CGEN) share and option holdings - Stock Titan
Compugen (CGEN) COO discloses 400,000 share options in Form 3 - Stock Titan
Compugen (CGEN) director Anat Cohen-Dayag reports initial share and option holdings - Stock Titan
Compugen (CGEN) SVP reports RSU and option stakes in Form 3 filing - Stock Titan
Sectors Review: What is the cash position of Compugen Ltd2026 Price Momentum & Safe Capital Preservation Plans - baoquankhu1.vn
Movement Recap: Whats the analyst consensus on Compugen LtdWeekly Risk Report & AI Forecasted Stock Moves - baoquankhu1.vn
Compugen Ltd. (CGEN) reports Q4 revenue of $67.3 million vs. $1.5 million last year - MSN
Institution Moves: How is Compugen Ltd managing supply chain issuesQuarterly Earnings Summary & Weekly Chart Analysis and Guides - baoquankhu1.vn
Compugen Ltd. (CGEN) Reports Q4 Revenue of $67.3 Million vs. $1.5 Million Last Year - Insider Monkey
Compugen (CGEN) Q4 2025 Earnings Call Transcript - AOL.com
Compugen at Leerink Global Healthcare Conference: Strategic Insights By Investing.com - Investing.com Australia
Compugen at Leerink Global Healthcare Conference: Strategic Insights - Investing.com South Africa
Short Squeeze: Is Compugen Ltd stock forming a triangle pattern2026 PreEarnings & Consistent Growth Stock Picks - baoquankhu1.vn
CGEN Earnings History & Surprises | EPS & Revenue Results | COMPUGEN LTD (NASDAQ:CGEN) - ChartMill
Q1 Earnings Estimate for Compugen Issued By HC Wainwright - Defense World
BillionToOne Stock at $89: Why a New $19.1 Million Position Could Matter Now - AOL.com
3 Reasons Exelixis Stock Could Deliver Market‑Beating Returns Over the Next Decade - AOL.com
Compugen Q4 Earnings Call Highlights - Defense World
Compugen Ltd (CGEN) Q4 2025 Earnings Call Highlights: Strong Rev - GuruFocus
Why Tempus AI Stock Is Up Today — And What to Watch Before Next Week’s Earnings - AOL.com
Cumberland (CPIX) Q4 2025 Earnings Call Transcript - AOL.com
Compugen Ltd. (NASDAQ:CGEN) Q4 2025 Earnings Call Transcript - Insider Monkey
Compugen (CGEN) Quarterly Loss Near US$7 Million Tests Bullish Profitability Narrative - simplywall.st
From Sizable Stake to Zero: The Likely Reason Why Agios Shares Lost a $94 Million Backer - AOL.com
Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing - AOL.com
Compugen earnings beat by $0.68, revenue topped estimates - Investing.com South Africa
Chegg Earnings: Big Quarter Sends Shares Higher - AOL.com
Compugen: Non-Dilutive Funding For Rilvegostomig Obtained And GS-0321 Advancement (CGEN) - Seeking Alpha
Compugen Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Compugen Q4 2025 Earnings Call Transcript - MarketBeat
Compugen Ltd. Q4 2025 Earnings Call Summary - Yahoo Finance
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
What Smart Money Loves About Lilly - AOL.com
Viridian Therapeutics Stock Up 75%, but One Fund Just Sold Off Its $69 Million Stake - AOL.com
Earnings call transcript: Compugen Q4 2025 sees earnings beat, stock surges - Investing.com
CGEN: 2025 saw a cash runway extension, profitability, and global clinical trial progress - TradingView
Compugen Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
CGEN: 2025 saw strong revenue growth, a return to profitability, and extended cash runway into 2029 - TradingView
Compugen: Overview of Fourth Quarter Financial Results - Bitget
Compugen (CGEN) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
Compugen Extends Cash Runway to 2029 and Swings to Profit on AstraZeneca Deal and Clinical Progress - TipRanks
Partnership payments lift Compugen (NASDAQ: CGEN) to 2025 profit - Stock Titan
Compugen Ltd (CGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):